Waleed is MIC Deputy Group CEO and has strategic oversight of MIC’s broad investment portfolio and special projects at the MIC Group level. He is also a member of the investment committee, which is mandated to develop MIC’s investment policies, establish investment guidelines, and review proposed projects and investments to ensure they are in line with business objectives.

Waleed is also the Chairman of the MIC Investment and Business Planning Committee, which approves deals within a certain financial threshold in addition to being responsible for annual and multi-year business planning. Furthermore, Waleed has oversight of the UAE Investments, Real Assets and Credit and Special Situations platforms.

Prior to joining the MIC Group, Waleed worked with the UAE Offsets Programme Bureau as a senior projects manager. His past roles also include working with McKinsey & Company as a commercial and governmental consultant.

Education: Bachelor of Science degree in Foreign Service from Georgetown University, Edmund A. Walsh School of Foreign Service; Master’s degree in Public Policy from Harvard University, both in the U.S.A.

Board Positions: Chairman of Waha Capital, Global Institute for Disease Elimination (GLIDE), the U.S.-UAE Business Council, Mubadala Capital and Vice Chair of M42, and Aldar. In addition, Waleed is a member of the Board of Trustees of Cleveland Clinic in the United States. He is also a board member of First Abu Dhabi Bank, Hub71, Abu Dhabi Investment Council, Getir, and Noon.com

Waleed was recently appointed as a member of the Board of L’IMAD Holding Company.